At a $253M market cap, MCR trades at 14.5x earnings and just 0.9x book, which immediately signals a potential asset-based discount in an asset management vehicle. The absence of a Forward P/E and Altman Z-Score eliminates forward visibility into earnings durability and balance sheet safety, which is a material analytical gap. A 14.1x Price/Sales ratio is elevated relative to its modest 6.20% operating margin, suggesting the market is paying up for revenue despite limited operating efficiency. With ROIC at 6.00% and TTM yield listed at 0.3, this does not screen as a high-return compounder or an income powerhouse. The stock looks statistically “cheap to book” but not obviously mispriced without clearer growth or balance sheet data.
⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.